MassBio Reports on Life Sciences Workforce Needs and Challenges

The Massachusetts Biotechnology Council (MassBio) has released a study identifying workforce needs, expectations, and challenges across the Massachusetts life sciences industry. Findings from 129 biopharma companies show that 78 percent expect to grow their workforce over the next 12 months with both entry- and non-entry-level new hires, with most also having experienced difficulty in filling open positions during the last year. MassBio’s industry snapshot released last year identified a near-term demand of up to 40,000 new workers by 2024.

The study offers specific short-term interventions and long-term strategies to inform how the life sciences ecosystem can supply a workforce to meet the industry’s anticipated growth. These recommendations include focusing on non-four-year degree pathways with hands-on experience, partnerships with Minority Serving Institutions, increasing career awareness in younger students, and centralizing workforce development efforts. The focus of the recommendations and a priority for MassBio is to improve access for underrepresented and disadvantaged populations including women and people of color to opportunities by meeting them where they are geographically, educationally, culturally, and in life.

“This report reinforces the strength of the Massachusetts life sciences industry and reveals what companies are looking for from job candidates and how the ecosystem must adjust the traditional talent pipeline to meet the demand,” said Joe Boncore, CEO of MassBio. “Continued collaboration between government, academia and companies is critical to better fill roles and prepare applicants for careers, and this study provides us the data to take action.”

Between 2006 and 2021, the Massachusetts life sciences industry labor market more than doubled (131 percent) while the overall statewide labor market grew by 6.9 percent. Life sciences growth far outpaced utilities, education, construction, retail, finance, and insurance. The survey notes that research and development and pharmaceutical manufacturing are central to the state’s life sciences labor market. (Source: MassBio Website, 01 June, 2022)